Perceptive Advisors - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$4,279,000735,1650.12%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders